Extra-virgin olive oil and its phenolic extract prevent inflammatory response and joint damage in murine experimental arthritis
DOI:
https://doi.org/10.3989/gya.0449161Keywords:
CIA, EVOO, Inflammatory response, Olive oil, Polyphenols, Rheumatoid arthritisAbstract
The consumption of EVOO in Mediterranean countries has shown beneficial effects. A wide range of evidence indicates that the phenolic compounds present in EVOO are endowed with anti-inflammatory properties. In this work, we evaluated the effects of dietary EVOO and treatment with its phenolic extract (PE) in a model of RA, the collagen-induced arthritis (CIA) in mice. On day 0, DBA-1/J mice were immunized with bovine collagen type II (CII). On day 21, the mice received a booster injection. We have demonstrated that EVOO and its PE decreases joint edema, cell migration, cartilage degradation and bone erosion. Our data indicate that dietary EVOO and PE treatment inhibit JNK, p38 and signal transducer and STAT-3. In addition, both EVOO and PE decrease NF-κB translocation leading to the down-regulation of the arthritic process. These results support the interest of natural diet components in the development of therapeutic products for arthritic conditions.
Downloads
References
Aaronson DS, Horvath CM. 2002. A road map for those who don't know JAK-STAT. Science 296, 1653–1655. https://doi.org/10.1126/science.1071545
Alarcón de la Lastra C, Barranco MD, Motilva V, Herrerias JM. 2001. Mediterranean diet and health: biological importance of olive oil. Curr Pharm Des. 7, 933–950. https://doi.org/10.2174/1381612013397654 PMid:11472248
Bermúdez B, López S, Ortega A, Varela LM, Pacheco YM, Abia R, Muriana FJ. 2011. Oleic acid in olive oil: from a metabolic framework toward a clinical perspective. Curr. Pharm. Des. 17, 831–843. https://doi.org/10.2174/138161211795428957 PMid:21443481
Cárdeno A, Sánchez-Hidalgo M, Alarcón-de-la-Lastra C. 2013. An up-date of olive oil phenols in inflammation and cancer: molecular mechanisms and clinical implications. Curr. Med. Chem. 20, 4758–4776. https://doi.org/10.2174/09298673113209990159 PMid:23834184
Carrillo C, Cavia M, Alonso-Torre S. 2012. Role of oleic acid in immune system; mechanism of action; a review. Nutr Hosp. 27, 978–990. PMid:23165533
Gong D, Geng C, Jiang L, Cao J, Yoshimura H, Zhong L. 2009. Effects of hydroxytyrosol-20 on carrageenan-induced acute inflammation and hyperalgesia in rats. Phytother Res. 23, 646–650. https://doi.org/10.1002/ptr.2686 PMid:19067390
Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, Firestein GS. 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108, 73–81. https://doi.org/10.1172/JCI12466 PMid:11435459 PMCid:PMC209341
Impellizzeri D, Esposito E, Mazzon E, Paterniti I, Di Paola R, Morittu VM, Procopio A, Britti D, Cuzzocrea S. 2011. Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice. J. Pharmacol. Exp. Ther. 339, 859–869. https://doi.org/10.1124/jpet.111.182808 PMid:21880869
Jeong JG, Kim JM, Cho H, Hahn W, Yu SS, Kim S. 2004. Effects of IL-1beta on gene expression in human rheumatoid synovial fibroblasts. Biochem. Biophys. Res. Commun. 324, 3–7. https://doi.org/10.1016/j.bbrc.2004.09.011 PMid:15464974
Martínez-Domínguez E, de la Puerta R, Ruiz-Gutiérrez V. 2001. Protective effects upon experimental inflammation models of a polyphenol-supplemented virgin olive oil diet. Inflamm. Res. 50, 102–106. PMid:11289653
Morel J, Berenbaum F. 2004. Signal transduction pathways: new targets for treating rheumatoid arthritis. Joint Bone Spine 71, 503–510. https://doi.org/10.1016/j.jbspin.2004.03.004 PMid:15589430
Okamoto H, Yoshio T, Kaneko H, Yamanaka H. 2010. Inhibition of NF-kappaB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis. Arthritis Rheum. 62, 82–92. https://doi.org/10.1002/art.25063 PMid:20039418
Omar SH. 2010. Oleuropein in olive and its pharmacological effects. Sci. Pharm. 78, 133–154. https://doi.org/10.3797/scipharm.0912-18 PMid:21179340 PMCid:PMC3002804
Puertollano MA, Puertollano E, Álvarez de Cienfuegos G, de Pablo Martínez MA. 2010. Olive oil, immune system and infection. Nutr. Hosp. 25, 1–8. PMid:20204249
Rudan I, Sidhu S, Papana A, Meng SJ, Xin-Wei Y, Wang W, Campbell-Page RM, Demaio AR, Nair H, Sridhar D, Theodoratou E, Dowman B, Adeloye D, Majeed A, Car J, Campbell H, Wang W, Chan KY. 2015. Prevalence of rheumatoid arthritis in low- and middle-income countries: A systematic review and analysis. J. Glob. Health 5, 010409. PMid:25969732 PMCid:PMC4416333
Salgado E, Maneiro JR. 2014. New therapies for rheumatoid arthritis. Med. Clin. (Barc) 143, 461–466. https://doi.org/10.1016/j.medcli.2013.11.011 PMid:24461738
Smedslund G, Byfuglien MG, Olsen SU, Hagen KB. 2010. Effectiveness and safety of dietary interventions for rheumatoid arthritis: a systematic review of randomized controlled trials. J. Am. Diet Assoc. 110, 727–735. https://doi.org/10.1016/j.jada.2010.02.010 PMid:20430134
Suzuki M, Tetsuka T, Yoshida S, Watanabe N, Kobayashi M, Matsui N, Okamoto T. 2000. The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts. FEBS Lett. 465, 23–27. https://doi.org/10.1016/S0014-5793(99)01717-2
Vázquez-Roncero A, Janer del Valle M, Janer del Valle L. 1976. Determinación de los polifenoles totales del aceite de oliva. Grasas Aceites 24, 350–357.
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Consejo Superior de Investigaciones Científicas (CSIC)

This work is licensed under a Creative Commons Attribution 4.0 International License.
© CSIC. Manuscripts published in both the print and online versions of this journal are the property of the Consejo Superior de Investigaciones Científicas, and quoting this source is a requirement for any partial or full reproduction.
All contents of this electronic edition, except where otherwise noted, are distributed under a Creative Commons Attribution 4.0 International (CC BY 4.0) licence. You may read the basic information and the legal text of the licence. The indication of the CC BY 4.0 licence must be expressly stated in this way when necessary.
Self-archiving in repositories, personal webpages or similar, of any version other than the final version of the work produced by the publisher, is not allowed.